Pharmacists' views on generic medicines: A review of the literature

Journal of Generic Medicines

Volumn 5, Issue 3, 2008, Pages 209-218

  Al Gedadi, Nabil Abdo ^a   Hassali, Mohamed Azmi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; GENERIC DRUG; PHENYTOIN;

ARTICLE; ASIA; BIBLIOGRAPHIC DATABASE; BIOEQUIVALENCE; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG QUALITY; DRUG USE; EUROPE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH ECONOMICS; INFORMATION RETRIEVAL; PATIENT; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; PHYSICIAN; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; UNITED STATES;

EID: 42449131677     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2008.7     Document Type: Article

References (32)

1. Lofgren, H. (2004). Generic drugs: International trends and policy developments in Australia. Austral. Health Rev. 27(1), 39-48.
2. Ioannides-Demos, L. L., Ibrahim, J. E. & McNeil, J. J. (2002). Reference-based pricing schemes: Effect on pharmaceutical expenditure, resource utilisation and health outcomes. PharmacoEconomics 20 9), 577-591.
3. King, D. R. & Kanavos, P. (2002). Encouraging the use of generic medicines: Implications for transition economies. Croatian Med. J. 43(4), 462-469.
4. McGavock, H. (1997). Strategies to improve the cost effectiveness of general practitioner prescribing. An international perspective. PharmacoEconomics 12(3), 307-311.
5. Ess, S. M., Schneeweiss, S. & Szucs, T. D. (2003). European healthcare policies for controlling drug expenditure European healthcare policies for controlling drug expenditure. PharmacoEconomics 21(2), 89-103.
6. Kirking, D. M., Gaither, C. A., Asicone, F. J. & Welage, L. S. (2001). Pharmacists' individual and organizational views on generic medications. J. Am. Pharm. Assoc. 41(5), 723-728.
7. Duane, M. K., Caroline, A. G., Frank, J. A. & Welage, L. S. (2001). Pharmacists' individual and organizational views on generic medications. J. Am. Pharm. Assoc. 41(5), 6.
8. Lewis, N. J. W. & Erickson, S. (1996). Pharmacists' performance in drug product selection and therapeutic interchange, in Smith, M. C., Wertheimer, A. I. (eds.), Social and Behavioral Aspects of Pharmaceutical Care, Haworth Press, New York, pp.185-207.
9. Mott, D. A. & Cline, R. R. (2002). Exploring generic drug use behavior: The role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med. Care 40(8 ), 662-674.
10. Christensen, T. P., Kirking, D. M., Ascione, F. J., Welage, L. S. & Gaither, C. A. (2001). Drug product selection: Legal issues. J. Am. Pharm. Assoc. (Washington) 41(6), 868-874.
11. Gaither, C. A., Kirking, D. M., Asicone, F. J. & Welage, L. S. (2001). Consumers' views on generic medications. J. Am. Pharm. Assoc. 41(5), 729-736.
12. Mason, J. B. & Bearden, W. O. (1980). Generic drugs: Consumer, pharmacist and physician perceptions of the issues. J. Consum. Aff. 14(1), 193-206.
13. Carroll, N. V., Siridhara, C. & Fincham, J. E. (1986). Perceived risks and pharmacists' generic substitution behavior. J. Consum. Aff. (1986-1998) 20(1), 36.
14. Carroll, N. V. & Wolfgang, A. P. (1989). Inherent risk and market acceptance of generic drug product. J. Health Care Market. 9 4), 48.
15. Segal, R., Wantz, D. L. & Brusadin, R. A. (1989). Pharmacists' decision making in the selection of generic pharmaceuticals. J. Pharmaceut. Market. Manage. 4(1), 17.
16. Carroll, N.V. & Wolfgang, A. P. (1991). Risks, benefits, and generic substitution. J. Consum. Aff. 25(1), 110.
17. Gupta, P. B. (1996). Survey of pharmacists: Impact of the generic drug scandal and implications for marketing generic drugs. Health Market. Quart. 13(3), 109.
18. Anonymous (1990). Consumer confidence in generic drug products down in wake of industry scandal but satisfaction with products remains high, survey reveals. AJHP 47(3), 468-476.
19. Anonymous (1991). After the storm: Has the scandal shaken your confidence? Drug Top. 135(12), 40.
20. Sanborn, M. D. & White, S. J. (1993). Pharmacists' perceptions and practices regarding the purchase of multisource pharmaceuticals. Hosp. Pharm. 28(2), 104-106, 9-13.
21. FDA US (2007). Approved Drug Products with Therapeutic Equivalence Evaluations, 27th edn, US Food and Drug Administration, Center for Drug Evaluation and Research 2007, Rockville, MD.
22. Maline, N. (1996). What your pharmacists think about generics. Drug Store News 18(13), 15.
23. Banahan, B. F. III & Kolassa, E. M. (1994). Generic Substitution and Narrow Therapeutic Index Drugs, A National Survey of Retail and Hospital Pharmacies, University of Mississippi, Mississpi.
24. Gandhi, S. K., Lively, B. T., Warren Salmon, J., Siganga, W. W. & Holiday-Goodman, M. (1997). Risk-taking propensity and drug product selection behavior of pharmacists. J. Managed Care Pharm. 3 4), 5.
25. Suh, D. C. (1999). Trends of generic substitution in community pharmacies. Pharm. World Sci. 21(6), 260-265.
26. Allenet, B. & Barry, H. (2003). Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: Survey of 1,000 French community pharmacists. Pharm. World Sci. 25(5 , 197-202.
27. Hassali, M. A., Kong, D. C. & Stewart, K. (2005). Generic medicines: Perceptions of community pharmacists in Melbourne, Australia. J. Pharma Fin. Econom. Pol. 14(3), 27-45.
28. Williams, A. E. & Chrystyn, H. (2007). Survey of pharmacists' attitudes towards interchangeable use of dry powder inhalers. Pharm. World Sci. 29(3), 221-227.
29. Anderson, K., Sonesson, C., Petzold, M., Carlsten, A. & Lonnroth, K. (2005). What are the obstacles to generic substitution. An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol. Drug Saf. 14(5), 341-348.
30. Ping, C. C., Hassali, M. A. & Bahari, M. B. (2007). A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia. Pharmacoepidemiol. Drug Saf. 17 1), 82-89.
31. Paraponaris, A., Verger, P., Desquins, B., Villani, P., Bouvenot, G., Rochaix, L., Gourheux, J. C. and Moatti, J. P. (2004). Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Pol. 70(1), 23-32.
32. Ascione, F. J., Kirking, D. M., Gaither, C. A. & Welage, L. S. (2001). Historical overview of generic medication policy. J. Am. Pharm. Assoc. (Washington) 41(4), 567-577.